Cabaletta Bio (CABA) Capital Expenditures (2019 - 2025)
Cabaletta Bio's (CABA) quarterly Capital Expenditures came in at -$43000.0 in Q3 2025, down 117.0% year-on-year from $253000.0 in Q3 2024, and up 94.2% quarter-over-quarter from -$742000.0 in Q2 2025.
Cabaletta Bio (CABA) Capital Expenditures (2019 - 2025) Analysis & Trends
Cabaletta Bio's Capital Expenditures history runs 7 years deep, the most recent figure standing at -$43000.0 for Q3 2025.
- On a quarterly basis, Capital Expenditures fell 117.0% year-over-year to -$43000.0 in Q3 2025; TTM through Sep 2025 was $376000.0, a 81.52% decrease from a year earlier, with the FY2024 full-year figure at $2.2 million, up 214.96% from the prior year.
- Capital Expenditures grew to -$43000.0 in Q3 2025 per CABA's latest filing, from -$742000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.7 million in Q3 2022 and bottomed at -$2.1 million in Q4 2022.
- The 5-year median for Capital Expenditures is $261000.0 (2022), against an average of $226611.1.
- Across the five-year window, Capital Expenditures plunged 374.07% in 2021 and surged 3900.0% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $1.1 million in 2021, then sank by 296.06% to -$2.1 million in 2022, then jumped by 109.36% to $200000.0 in 2023, then jumped by 88.0% to $376000.0 in 2024, then sank by 111.44% to -$43000.0 in 2025.
- Per Business Quant, the three latest CABA Capital Expenditures figures stand at -$43000.0 (Q3 2025), -$742000.0 (Q2 2025), and $785000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Cabaletta Bio | 182.04 Mn | 182.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -43,000.00 |
| Sep 30, 2025 | -43,000.00 |
| Jun 30, 2025 | -742,000.00 |
| Jun 30, 2025 | -742,000.00 |
| Mar 31, 2025 | 785,000.00 |
| Mar 31, 2025 | 785,000.00 |
| Dec 31, 2024 | 376,000.00 |
| Dec 31, 2024 | 376,000.00 |
| Sep 30, 2024 | 253,000.00 |
| Sep 30, 2024 | 253,000.00 |
| Jun 30, 2024 | 920,000.00 |
| Jun 30, 2024 | 920,000.00 |
| Mar 31, 2024 | 662,000.00 |
| Mar 31, 2024 | 662,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 479,000.00 |
| Sep 30, 2023 | 479,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 23,000.00 |